Streetbeat News

Regulatory

CVLY

ORRF

Orrstown Financial Services and Codorus Valley Bancorp have received the necessary regulatory approvals and waivers for their merger of equals.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 12:37 pm

TANH

Tantech Holdings Ltd (NASDAQ:TANH) has regained compliance with Nasdaq's periodic filing requirement under Listing Rule 5250(c)(1). Nasdaq has confirmed that the matter is now closed.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 12:34 pm

AVTE

Trading in AVTE was halted at 8:25:00 a.m. ET pending news. Investors should stay tuned for updates as trading halts often precede significant announcements.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 12:25 pm

MRCY

Mercury Systems and Green Hills Software have entered the verification phase to provide DO-178C and AC 20-193 airworthiness evidence for the INTEGRITY-128 tuMP safety-critical real-time operating system.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 12:17 pm

THAR

Tharimmune has reported a Type C meeting with the FDA regarding its Phase 2 program for TH104. This meeting is a significant step in the drug development process, potentially impacting the company's future prospects.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 12:15 pm

BTCUSD

COIN

A significant Bitcoin and blockchain roundtable organized by U.S. Congressman Ro Khanna will take place in Washington D.C. in early July. The event will feature key officials from the Biden Administration, members of Congress, and Mark Cuban. This meeting is seen as a response to former President Donald Trump's recent endorsements of Bitcoin. The Biden Administration has historically taken a critical stance towards Bitcoin, but this roundtable could signal a potential shift in Washington's approach to the crypto industry.

Portfolio Pulse from Murtuza Merchant

June 17, 2024 | 12:10 pm

TNXP

Tonix Pharmaceuticals presented positive Phase 3 study results for Tonmya in managing fibromyalgia at the EULAR 2024 conference. The study showed significant pain reduction and symptom improvement, with an NDA submission to the FDA expected in the second half of 2024.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 12:09 pm

HUMA

Humacyte, Inc. (NASDAQ:HUMA) announced the issuance of four new ICD-10-PCS codes by the Centers for Medicare & Medicaid Services for procedures using its Human Acellular Vessels (HAVs). These codes will be effective from October 1, 2024. Additionally, the FDA has given the HAV a common name: 'acellular tissue engineered vessel' (ATEV).

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 12:06 pm

BTM

Bitcoin Depot has announced plans to allocate its cash reserves to Bitcoin, with future purchases being opportunistic to support growth opportunities. This follows the ASU 2023-08 update, which allows companies to record cryptocurrency gains.

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 12:04 pm

JNJ

Johnson & Johnson has submitted an FDA application for a fixed combination of Amivantamab and Recombinant Human Hyaluronidase for subcutaneous administration. This combination is intended for all currently approved or submitted indications of IV Rybrevant in certain types of non-small cell lung cancer (NSCLC).

Portfolio Pulse from Benzinga Newsdesk

June 17, 2024 | 12:04 pm